We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

NNAL Clearance in Hair and Urine (NNAL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00863824
Recruitment Status : Withdrawn (Study was not funded)
First Posted : March 18, 2009
Last Update Posted : September 12, 2017
Information provided by (Responsible Party):

Study Description
Brief Summary:
The purpose of the study is to investigate how long it takes for NNAL and cotinine, both specific markers of second hand tobacco smoke exposure to clear the human body.

Condition or disease
Lung Cancer

Study Design

Study Type : Observational
Actual Enrollment : 0 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Elimination of NNAL and Cotinine From Hair and Urine
Study Start Date : July 2009
Estimated Primary Completion Date : May 2010
Estimated Study Completion Date : June 2010

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   19 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Healthy Caucasians and African Americans who are ready to quit smoking.

Inclusion Criteria:

  • Healthy caucasians and african americans 19 years of agae or above, how are ready to quit smoking

Exclusion Criteria:

  • Anyone who is not a caucasian or an african-american, below 19 years of age, and is currently taken prescription medication.
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00863824

United States, Nebraska
University of Nebraska Medical Center
Omaha, Nebraska, United States, 68198
Sponsors and Collaborators
University of Nebraska
Centers for Disease Control and Prevention
More Information

Responsible Party: Chandran Achutan, PhD, Principal Investigator, University of Nebraska
ClinicalTrials.gov Identifier: NCT00863824     History of Changes
Other Study ID Numbers: 121-09-EP
First Posted: March 18, 2009    Key Record Dates
Last Update Posted: September 12, 2017
Last Verified: September 2017

Keywords provided by Chandran Achutan, PhD, University of Nebraska:
Second hand smoke
NNAL is a known lung carcinogen. So, we are studying an agent that can potentially cause lung cancer.